140 related articles for article (PubMed ID: 10588823)
1. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer.
Castro MR; Bergert ER; Beito TG; Roche PC; Ziesmer SC; Jhiang SM; Goellner JR; Morris JC
J Endocrinol; 1999 Dec; 163(3):495-504. PubMed ID: 10588823
[TBL] [Abstract][Full Text] [Related]
2. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells.
Castro MR; Bergert ER; Beito TG; McIver B; Goellner JR; Morris JC
J Clin Endocrinol Metab; 1999 Aug; 84(8):2957-62. PubMed ID: 10443704
[TBL] [Abstract][Full Text] [Related]
3. Expression of the sodium iodide symporter in human kidney.
Spitzweg C; Dutton CM; Castro MR; Bergert ER; Goellner JR; Heufelder AE; Morris JC
Kidney Int; 2001 Mar; 59(3):1013-23. PubMed ID: 11231356
[TBL] [Abstract][Full Text] [Related]
4. Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.
Caillou B; Troalen F; Baudin E; Talbot M; Filetti S; Schlumberger M; Bidart JM
J Clin Endocrinol Metab; 1998 Nov; 83(11):4102-6. PubMed ID: 9814499
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
[TBL] [Abstract][Full Text] [Related]
6. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands.
Spitzweg C; Joba W; Schriever K; Goellner JR; Morris JC; Heufelder AE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4178-84. PubMed ID: 10566669
[TBL] [Abstract][Full Text] [Related]
7. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
8. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
9. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.
Spitzweg C; Joba W; Eisenmenger W; Heufelder AE
J Clin Endocrinol Metab; 1998 May; 83(5):1746-51. PubMed ID: 9589686
[TBL] [Abstract][Full Text] [Related]
10. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters.
Pohlenz J; Duprez L; Weiss RE; Vassart G; Refetoff S; Costagliola S
J Clin Endocrinol Metab; 2000 Jul; 85(7):2366-9. PubMed ID: 10902780
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues.
Jhiang SM; Cho JY; Ryu KY; DeYoung BR; Smanik PA; McGaughy VR; Fischer AH; Mazzaferri EL
Endocrinology; 1998 Oct; 139(10):4416-9. PubMed ID: 9751526
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
Joba W; Spitzweg C; Schriever K; Heufelder AE
Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
Seissler J; Wagner S; Schott M; Lettmann M; Feldkamp J; Scherbaum WA; Morgenthaler NG
J Clin Endocrinol Metab; 2000 Dec; 85(12):4630-4. PubMed ID: 11134119
[TBL] [Abstract][Full Text] [Related]
14. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
15. Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues.
Liou MJ; Lin JD; Chan EC; Liu FH; Chao TC; Weng HF
Cancer Lett; 2000 Nov; 160(1):75-80. PubMed ID: 11098087
[TBL] [Abstract][Full Text] [Related]
16. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
17. Expression of sodium iodide symporter in benign and malignant human thyroid tissues.
Lin JD; Hsueh C; Chao TC; Weng HF
Endocr Pathol; 2001; 12(1):15-21. PubMed ID: 11478264
[TBL] [Abstract][Full Text] [Related]
18. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line.
Smit JW; Shröder-van der Elst JP; Karperien M; Que I; van der Pluijm G; Goslings B; Romijn JA; van der Heide D
Thyroid; 2000 Nov; 10(11):939-43. PubMed ID: 11128720
[TBL] [Abstract][Full Text] [Related]
19. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter.
Smanik PA; Ryu KY; Theil KS; Mazzaferri EL; Jhiang SM
Endocrinology; 1997 Aug; 138(8):3555-8. PubMed ID: 9231811
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical studies of Na+/I- symporter in human thyroid tissues--a correlation with clinical thyroid scintigraphy.
Lee CH; Yang AH; Chang JY; Huang CL; Chi CW
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Mar; 64(3):141-6. PubMed ID: 11458618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
